Ovarian Cancer
Ovarian Cancer News & Features
A multipronged initiative increased germline BRCA mutation testing for patients with ovarian cancer by 31%.
A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.
Individual lifetime ovulatory years components associated with epithelial ovarian cancer apart from age at menarche.
Mirvetuximab soravtansine has shown activity in a phase 2 trial of biomarker-selected patients with platinum-resistant ovarian cancer.
The consumption of ultra-processed foods is associated with an increased risk of developing cancer and dying from it, a large study suggests.
Ovarian Cancer Clinical Trials
Next post in Ovarian Cancer
Loading...
Loading...